NAFLD, nonalcoholic fatty liver disease; FBS, fasting blood sugar; ALT, alanine aminotransferase; AST, aspartateaminotransferase; HOMA-IR, homeostatic model assessment—insulin resistance. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.